Acute feasibility study of a novel device for the treatment of mitral regurgitation in a normal canine model

Tohru Takaseya, Hideyuki Fumoto, Roberto M. Saraiva, Akira Shiose, Yoko Arakawa, Margaret Park, Santosh Rao, Raymond Dessoffy, Larry D. Kramer, Mark Juravic, Pierluca Lombardi, Kiyotaka Fukamachi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: The purpose of this study was to evaluate the implantability of a novel epicardial mitral annuloplasty device and its ability to reduce the septal-lateral (S-L) dimension of the mitral annulus. Methods: The devices were implanted on the beating heart in 2 healthy dogs (the 24-mm long device in dog A and the 27-mm and 24-mm standard devices in dog B) by sliding the anterior arm onto the floor of the transverse sinus and positioning the posterior arm just apical to the atrioventricular groove on the left ventricular posterolateral wall. The devices were secured with titanium helical tacks driven through the device into the ventricular wall. Two-dimensional epicardial echocardiograms were performed before and after device implantation to evaluate the degree of mitral regurgitation (MR) and the S-L dimension. Results: Device implantation was uneventful, taking only ∼30 seconds to deploy. MR (1+) in both dogs at baseline was reduced to zero after implant. The reductions in S-L dimension in systole for the 24-mm device were 7.5% in dog A and 30.5% in dog B. For the 27-mm device in dog B, S-L reduction in systole was 29.9%. The leaflet coaptation length was increased in both cases. Conclusions: The new device was effective in reducing S-L dimension and 1+ MR without requiring the use of cardiopulmonary bypass. We are currently evaluating this device for the treatment of MR in a rapid-pacing canine heart failure model.

Original languageEnglish
Pages (from-to)28-32
Number of pages5
JournalInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Volume5
Issue number1
DOIs
Publication statusPublished - Jan 1 2010
Externally publishedYes

Fingerprint

Mitral Valve Insufficiency
Feasibility Studies
Canidae
Equipment and Supplies
Dogs
Systole
Mitral Valve Annuloplasty
Transverse Sinuses
Titanium
Cardiopulmonary Bypass
Heart Failure

All Science Journal Classification (ASJC) codes

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Acute feasibility study of a novel device for the treatment of mitral regurgitation in a normal canine model. / Takaseya, Tohru; Fumoto, Hideyuki; Saraiva, Roberto M.; Shiose, Akira; Arakawa, Yoko; Park, Margaret; Rao, Santosh; Dessoffy, Raymond; Kramer, Larry D.; Juravic, Mark; Lombardi, Pierluca; Fukamachi, Kiyotaka.

In: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, Vol. 5, No. 1, 01.01.2010, p. 28-32.

Research output: Contribution to journalArticle

Takaseya, T, Fumoto, H, Saraiva, RM, Shiose, A, Arakawa, Y, Park, M, Rao, S, Dessoffy, R, Kramer, LD, Juravic, M, Lombardi, P & Fukamachi, K 2010, 'Acute feasibility study of a novel device for the treatment of mitral regurgitation in a normal canine model', Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, vol. 5, no. 1, pp. 28-32. https://doi.org/10.1097/IMI.0b013e3181cdf735
Takaseya, Tohru ; Fumoto, Hideyuki ; Saraiva, Roberto M. ; Shiose, Akira ; Arakawa, Yoko ; Park, Margaret ; Rao, Santosh ; Dessoffy, Raymond ; Kramer, Larry D. ; Juravic, Mark ; Lombardi, Pierluca ; Fukamachi, Kiyotaka. / Acute feasibility study of a novel device for the treatment of mitral regurgitation in a normal canine model. In: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2010 ; Vol. 5, No. 1. pp. 28-32.
@article{bcaffe5080734d4c94f7147ac177206d,
title = "Acute feasibility study of a novel device for the treatment of mitral regurgitation in a normal canine model",
abstract = "Objective: The purpose of this study was to evaluate the implantability of a novel epicardial mitral annuloplasty device and its ability to reduce the septal-lateral (S-L) dimension of the mitral annulus. Methods: The devices were implanted on the beating heart in 2 healthy dogs (the 24-mm long device in dog A and the 27-mm and 24-mm standard devices in dog B) by sliding the anterior arm onto the floor of the transverse sinus and positioning the posterior arm just apical to the atrioventricular groove on the left ventricular posterolateral wall. The devices were secured with titanium helical tacks driven through the device into the ventricular wall. Two-dimensional epicardial echocardiograms were performed before and after device implantation to evaluate the degree of mitral regurgitation (MR) and the S-L dimension. Results: Device implantation was uneventful, taking only ∼30 seconds to deploy. MR (1+) in both dogs at baseline was reduced to zero after implant. The reductions in S-L dimension in systole for the 24-mm device were 7.5{\%} in dog A and 30.5{\%} in dog B. For the 27-mm device in dog B, S-L reduction in systole was 29.9{\%}. The leaflet coaptation length was increased in both cases. Conclusions: The new device was effective in reducing S-L dimension and 1+ MR without requiring the use of cardiopulmonary bypass. We are currently evaluating this device for the treatment of MR in a rapid-pacing canine heart failure model.",
author = "Tohru Takaseya and Hideyuki Fumoto and Saraiva, {Roberto M.} and Akira Shiose and Yoko Arakawa and Margaret Park and Santosh Rao and Raymond Dessoffy and Kramer, {Larry D.} and Mark Juravic and Pierluca Lombardi and Kiyotaka Fukamachi",
year = "2010",
month = "1",
day = "1",
doi = "10.1097/IMI.0b013e3181cdf735",
language = "English",
volume = "5",
pages = "28--32",
journal = "Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery",
issn = "1556-9845",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Acute feasibility study of a novel device for the treatment of mitral regurgitation in a normal canine model

AU - Takaseya, Tohru

AU - Fumoto, Hideyuki

AU - Saraiva, Roberto M.

AU - Shiose, Akira

AU - Arakawa, Yoko

AU - Park, Margaret

AU - Rao, Santosh

AU - Dessoffy, Raymond

AU - Kramer, Larry D.

AU - Juravic, Mark

AU - Lombardi, Pierluca

AU - Fukamachi, Kiyotaka

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Objective: The purpose of this study was to evaluate the implantability of a novel epicardial mitral annuloplasty device and its ability to reduce the septal-lateral (S-L) dimension of the mitral annulus. Methods: The devices were implanted on the beating heart in 2 healthy dogs (the 24-mm long device in dog A and the 27-mm and 24-mm standard devices in dog B) by sliding the anterior arm onto the floor of the transverse sinus and positioning the posterior arm just apical to the atrioventricular groove on the left ventricular posterolateral wall. The devices were secured with titanium helical tacks driven through the device into the ventricular wall. Two-dimensional epicardial echocardiograms were performed before and after device implantation to evaluate the degree of mitral regurgitation (MR) and the S-L dimension. Results: Device implantation was uneventful, taking only ∼30 seconds to deploy. MR (1+) in both dogs at baseline was reduced to zero after implant. The reductions in S-L dimension in systole for the 24-mm device were 7.5% in dog A and 30.5% in dog B. For the 27-mm device in dog B, S-L reduction in systole was 29.9%. The leaflet coaptation length was increased in both cases. Conclusions: The new device was effective in reducing S-L dimension and 1+ MR without requiring the use of cardiopulmonary bypass. We are currently evaluating this device for the treatment of MR in a rapid-pacing canine heart failure model.

AB - Objective: The purpose of this study was to evaluate the implantability of a novel epicardial mitral annuloplasty device and its ability to reduce the septal-lateral (S-L) dimension of the mitral annulus. Methods: The devices were implanted on the beating heart in 2 healthy dogs (the 24-mm long device in dog A and the 27-mm and 24-mm standard devices in dog B) by sliding the anterior arm onto the floor of the transverse sinus and positioning the posterior arm just apical to the atrioventricular groove on the left ventricular posterolateral wall. The devices were secured with titanium helical tacks driven through the device into the ventricular wall. Two-dimensional epicardial echocardiograms were performed before and after device implantation to evaluate the degree of mitral regurgitation (MR) and the S-L dimension. Results: Device implantation was uneventful, taking only ∼30 seconds to deploy. MR (1+) in both dogs at baseline was reduced to zero after implant. The reductions in S-L dimension in systole for the 24-mm device were 7.5% in dog A and 30.5% in dog B. For the 27-mm device in dog B, S-L reduction in systole was 29.9%. The leaflet coaptation length was increased in both cases. Conclusions: The new device was effective in reducing S-L dimension and 1+ MR without requiring the use of cardiopulmonary bypass. We are currently evaluating this device for the treatment of MR in a rapid-pacing canine heart failure model.

UR - http://www.scopus.com/inward/record.url?scp=76449084780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76449084780&partnerID=8YFLogxK

U2 - 10.1097/IMI.0b013e3181cdf735

DO - 10.1097/IMI.0b013e3181cdf735

M3 - Article

VL - 5

SP - 28

EP - 32

JO - Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

JF - Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

SN - 1556-9845

IS - 1

ER -